Global AD

Collapse

Announcement

Collapse
No announcement yet.

JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • JAK1 inhibitor abrocitinib for the treatment of steroid-induced rosacea: case series

    CONCLUSION: The JAK1 inhibitor abrocitinib is a promising potential treatment for steroid-induced rosacea.

    More...
Working...
X